About Jennifer Rider
- Low vitamin D levels in blood have been shown in numerous population-based studies to correlate with prostate cancer mortality. Also, several genetic alterations in the vitamin-D pathway-related genes have been shown to be associated with a risk of death from prostate cancer.
- Dr. Rider’s studies will investigate a link between vitamin D levels, lethal prostate cancer and the presence of prostatic infection.
- These investigations should contribute to an understanding of the etiology of the lethal form of prostate cancer.
What this means for patients: The outcomes of this research will help stratify patient risk for lethal prostate cancer.
2013 Michael & Lori Milken-PCF Young Investigator
Jennifer Rider, ScD
Harvard School of Public Health
Lorelei Mucci, ScD and Myles Brown, MD
The immunomodulatory and androgen-associated actions of vitamin D in prostate cancer